Replies to post #538827 on NorthWest Biotherapeutics Inc (NWBO)

[rizona]

They need the shares to supply common shares to warrant converters and purchasers of class c shares. Suppose...BP buys the class c shares so they have the votes (25 per class c share) to ram through a buy out. Then, the shares convert to common and the BO leads to BP paying themselves during a BO.

[biosectinvestor]

If a buyout was on the table, why would they need a lot more shares? That doesn’t make sense. The buyer wants your shares and mine. The company does need to issue shares to investors who are owed shares, if any, and also to negotiate and keep things going, particularly if the buyout is only triggered on a still pending event like approval of the commercial license, filing of the marketing application or having it approved.

And as for what someone said about Project Orbis, the U.K. ILAP program would make them eligible to enter that program on the referral of the MHRA for the UK. There is no indication from this filing that suddenly that is “not” in potential play.